Published In
Urology Research and Practice
Volume 46 · Issue 4
Pages: 274-276
History
Published Online: July 6, 2020
Copyright © 2020 Urology Research and Practice
Elsayed Desouky
Department of Urology, Wexham Park NHS Hospital, Berkshire, UK
Desouky, E. (2020). Intravesical BCG amid COVID-19: To give or not to give?. Urology Research and Practice, 46(4), 274–276. https://doi.org/10.5152/tud.2020.20206
Full Text
Full Text PDF
Full Text PDF
Abstract
During the coronavirus disease 2019 pandemic, there has been a reduction in the provision of all elective services. This poses enormous pressure on urologists as regards to patients with bladder cancer who need intravesical Bacille Calmette Guerin (BCG) treatment. The evolving situation of the pandemic mandates a pragmatic approach in clinical decisions; to date, there are no uniform consensus guidelines about how to manage these patients and the factors affecting our decision for service provision. These concerns need to be addressed not only for the current crisis but also for the upcoming next phase of the pandemic.
Cite this article as: Desouky E. Intravesical BCG amid COVID-19: To give or not to give? Turk J Urol 2020; 46(4): 274-6.
Similar Articles
Article Info
Published In
Journal
Urology Research and Practice
Volume / Issue
Volume 46 · Issue 4
Pages
274-276
History
Published Online
July 6, 2020
Copyright
Copyright (c) 2020 Urology Research and Practice
Affiliations
Elsayed Desouky
Department of Urology, Wexham Park NHS Hospital, Berkshire, UK
Cite this Article
Desouky, E. (2020). Intravesical BCG amid COVID-19: To give or not to give?. Urology Research and Practice, 46(4), 274–276. https://doi.org/10.5152/tud.2020.20206
Outlines